Low testosterone and high cholesterol levels in relation to all-cause, cardiovascular disease, and cancer mortality in White, Black, and Hispanic men: NHANES 1988–2015

被引：0
作者：
David S. Lopez
Wei-Chen Lee
Carlos Orellana Garcia
Paige Birkelbach Downer
Shaden Taha
Alejandro Villasante-Tezanos
Konstantinos K. Tsilidis
Kristen Peek
Markides Kyriakos
Steven Canfield
机构：
[1] University of Texas Medical Branch,Deparment of Preventive Medicine and Population Health
[2] UTMB Health School of Medicine,Department of Preventive Medicine and Population Health
[3] University of Texas Medical Branch,Deparment of Internal Medicine
[4] School of Public Health,Department of Epidemiology and Biostatistics
[5] Imperial College London,Department of Hygiene and Epidemiology
[6] University of Ioannina School of Medicine,Division of Urology
[7] UTHealth McGovern Medical School,undefined
来源：
Hormones | 2022年 / 21卷
关键词：
Serum testosterone; Cardiovascular; Cancer; Mortality;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：399 / 411
页数：12
相关论文
共 43 条
  • [31] The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) as a predictor of all-cause and cardiovascular mortality in US adults with diabetes or prediabetes: NHANES 1999-2018
    Yu, Binyang
    Li, Min
    Yu, Zongliang
    Zheng, Tao
    Feng, Xue
    Gao, Anran
    Zhang, Haoling
    Gao, Rui
    BMC MEDICINE, 2024, 22 (01):
  • [32] Is There a Difference in All-Cause Mortality Between Non-Hispanic Black and Non-Hispanic White Men With the Same Level of Education? Analyses Using the 2000-2011 National Health Interview Surveys
    Gilmore, Danielle R.
    Whitfield, Keith E.
    Thorpe, Roland J., Jr.
    AMERICAN JOURNAL OF MENS HEALTH, 2019, 13 (01)
  • [33] The serum uric acid-to-high-density lipoprotein cholesterol ratio is a predictor for all-cause and cardiovascular disease mortality: a cross-sectional study
    Li, Zhanbin
    Liu, Qiaoran
    Yao, Zhenyu
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [34] A dose-response meta-analysis to evaluate the relationship between high-density lipoprotein cholesterol and all-cause and cardiovascular disease mortality
    Liu, L.
    Han, M.
    Qie, R.
    Li, Q.
    Zhang, X.
    Zhang, J.
    Zhan, S.
    Zhang, L.
    Xu, Z.
    Zhang, C.
    Hong, F.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2022, 45 (03) : 551 - 562
  • [35] Low HbA1c levels and all-cause or cardiovascular mortality among people without diabetes: the US National Health and Nutrition Examination Survey 1999-2015
    Inoue, Kosuke
    Nianogo, Roch
    Telesca, Donatello
    Goto, Atsushi
    Khachadourian, Vahe
    Tsugawa, Yusuke
    Sugiyama, Takehiro
    Mayeda, Elizabeth Rose
    Ritz, Beate
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2021, 50 (04) : 1373 - 1383
  • [36] Fenofibrate add-on to statin treatment is associated with low all-cause death and cardiovascular disease in the general population with high triglyceride levels
    Kim, Kyung-Soo
    Hong, Sangmo
    Han, Kyungdo
    Park, Cheol-Young
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2022, 137
  • [37] Serum folate concentrations and all-cause, cardiovascular disease and cancer mortality: A cohort study based on 1999-2010 National Health and Nutrition Examination Survey (NHANES)
    Peng, Yang
    Dong, Bin
    Wang, Zhiqiang
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 219 : 136 - 142
  • [38] Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population -: The MONICA/KORA cohort study
    Meisinger, Christa
    Koenig, Wolfgang
    Baumert, Jens
    Doering, Angela
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (06) : 1186 - 1192
  • [39] Low- or high-dose preventive aspirin use and risk of death from all-cause, cardiovascular disease, and cancer: A nationally representative cohort study
    Chen, Yu
    Chen, Fuli
    Liao, Jie
    Han, Hukui
    Li, Gang
    Zhou, Long
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [40] Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes
    Andersson, C.
    van Gaal, L.
    Caterson, I. D.
    Weeke, P.
    James, W. P. T.
    Couthino, W.
    Finer, N.
    Sharma, A. M.
    Maggioni, A. P.
    Torp-Pedersen, C.
    DIABETOLOGIA, 2012, 55 (09) : 2348 - 2355
12345